The store will not work correctly when cookies are disabled.
N-(3-(2-Aminophenyl)-3-oxopropyl)-4-chlorobenzimidamide
ID: ALA4868558
PubChem CID: 164621882
Max Phase: Preclinical
Molecular Formula: C16H16ClN3O
Molecular Weight: 301.78
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: N=C(NCCC(=O)c1ccccc1N)c1ccc(Cl)cc1
Standard InChI: InChI=1S/C16H16ClN3O/c17-12-7-5-11(6-8-12)16(19)20-10-9-15(21)13-3-1-2-4-14(13)18/h1-8H,9-10,18H2,(H2,19,20)
Standard InChI Key: QMWFPPBPJWLDQO-UHFFFAOYSA-N
Molfile:
RDKit 2D
21 22 0 0 0 0 0 0 0 0999 V2000
17.0363 -4.4457 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.0275 -3.6285 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.7476 -4.8472 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.3336 -4.8612 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.6223 -4.4597 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.9197 -4.8752 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.9243 -5.6923 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.6397 -6.0939 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.2217 -6.1120 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.2304 -6.9291 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.5278 -7.3447 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.8164 -6.9431 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.8077 -6.1260 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.5104 -5.7104 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.9417 -7.3266 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.7318 -3.2134 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.7235 -2.3971 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.0109 -1.9952 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.3053 -2.4157 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.3172 -3.2307 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.0011 -1.1781 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
1 3 2 0
1 4 1 0
5 6 1 0
6 7 1 0
7 8 2 0
9 10 1 0
10 11 2 0
11 12 1 0
12 13 2 0
13 14 1 0
9 14 2 0
10 15 1 0
7 9 1 0
4 5 1 0
2 16 2 0
16 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 2 1 0
18 21 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 301.78 | Molecular Weight (Monoisotopic): 301.0982 | AlogP: 3.11 | #Rotatable Bonds: 5 |
Polar Surface Area: 78.97 | Molecular Species: BASE | HBA: 3 | HBD: 3 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 11.06 | CX LogP: 3.07 | CX LogD: 0.67 |
Aromatic Rings: 2 | Heavy Atoms: 21 | QED Weighted: 0.34 | Np Likeness Score: -0.62 |
References
1. Arias F, Franco-Montalban F, Romero M, Carrión MD, Camacho ME.. (2021) Synthesis, bioevaluation and docking studies of new imidamide derivatives as nitric oxide synthase inhibitors., 44 [PMID:34218000] [10.1016/j.bmc.2021.116294] |